|
|
Volumn 57, Issue 3, 2002, Pages 231-239
|
|
An open label trial of sustained-release cytarabine (DepoCyt蒂) for the intrathecal treatment of solid tumor neoplastic meningitis
a b c d e f g h i j k l m n o p q r s t more.. |
|
Author keywords
Cerebrospinal fluid; Cytarabine; Intrathecal; Liposome; Neoplastic meningitis
|
|
Indexed keywords
ANTINEOPLASTIC ANTIMETABOLITE;
CYTARABINE;
DEXAMETHASONE;
LIPOSOME;
METHOTREXATE;
ADULT;
AGED;
ARTICLE;
BREAST TUMOR;
CLINICAL TRIAL;
DELAYED RELEASE FORMULATION;
DISEASE COURSE;
FEMALE;
HUMAN;
INTRASPINAL DRUG ADMINISTRATION;
MALE;
MENINGIOMA;
METASTASIS;
MIDDLE AGED;
MORTALITY;
MULTICENTER STUDY;
PATHOLOGY;
SURVIVAL;
ARACHNOIDITIS;
CANCER DIAGNOSIS;
CANCER RADIOTHERAPY;
CANCER SURVIVAL;
CEREBROSPINAL FLUID;
CEREBROSPINAL FLUID CYTOLOGY;
COMPUTER ASSISTED TOMOGRAPHY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOTOXICITY;
DISEASE SEVERITY;
DOSE RESPONSE;
DRUG CEREBROSPINAL FLUID LEVEL;
DRUG CLEARANCE;
DRUG RESPONSE;
DRUG SAFETY;
HEADACHE;
INJECTION;
LUMBAR PUNCTURE;
MAJOR CLINICAL STUDY;
MENINGITIS;
NEUROLOGICAL COMPLICATION;
NEUROTOXICITY;
NUCLEAR MAGNETIC RESONANCE IMAGING;
SLOW RELEASE FORMULATION;
SOLID TUMOR;
ADULT;
AGED;
ANTIMETABOLITES, ANTINEOPLASTIC;
BREAST NEOPLASMS;
CYTARABINE;
DELAYED-ACTION PREPARATIONS;
DISEASE PROGRESSION;
FEMALE;
HUMANS;
INJECTIONS, SPINAL;
MALE;
MENINGEAL NEOPLASMS;
MIDDLE AGED;
SURVIVAL ANALYSIS;
HUMAN;
MIDDLE AGE;
SUPPORT, NON-U.S. GOV'T;
|
|
EID: 0035990086
PISSN: 0167594X
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1015752331041 Document Type: Article |
|
Times cited : (114)
|
|
References (19)
|
